Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abnormal, accurate, accurately, admitted, AECB, analyst, antitrust, appraise, ARB, arbitration, ascertain, asssumed, bad, belief, Beneficial, book, bringing, Bunt, Bush, byC, byHelicobacter, campaign, capturing, card, chain, channel, Chapter, chargeback, clarify, Colangelo, collateral, consummated, COSO, curtail, customary, cycle, damage, damaged, deductible, defend, defending, defense, delivery, demand, deteriorate, dformylase, diminish, disadvantage, disclaim, dispensed, disposition, dispute, disruption, downturn, economically, emailing, encounter, encountered, enjoined, Esq, excessive, Expert, explanation, expose, extreme, feasibility, Feb, Fenner, FIFO, fifty, fill, firm, flexibility, formula, formulary, framework, Frameworkissued, freight, Gary, gathering, Genzyme, heading, ICS, idle, implied, impose, inadequate, inconsistent, incorrect, indenture, inInternal, Insider, Interference, intrinsic, john, judgemental, KIRBY, lapse, law, legacy, legislation, lose, Lynch, MA, managerial, Medicaid, Medicare, Merrill, Mexico, minimizing, mitigated, Morgan, naphthyridine, naphythyridine, nationwide, nausea, NDC, neighboring, Nick, opposition, OSCI, oscient, Oversight, PAMELA, partnership, passed, Patheon, Patou, payer, permanent, Pharmaco, Pierce, pledged, pneumococcal, postmarketing, premium, proceeding, prohibit, prohibited, promising, prove, PSS, qualification, reacquire, read, reluctant, renamed, requisite, resale, resolved, retrospective, saleable, salt, sample, Science, sending, shipping, Smith, speak, spoilage, standing, stockholder, tablet, talent, telithromycin, tenant, thereon, timetable, title, Ton, Treadway, turnover, unavailable, uncollectible, uncovered, undiscounted, unfavorable, unfavorably, unforeseen, uninsured, unpredictable, unrelated, update, valuable, vehicle, ViroPharma, visit, vulnerable, warehousing, warranty, wholesaler, Winter
Removed:
absence, administration, aimed, Andersen, annotate, antifungal, bacterium, bank, blood, cancer, characterization, check, cloning, commenced, component, compromised, copy, created, Creighton, deal, delinquent, density, duodenal, employ, environmental, exceed, family, frequently, functional, gastric, healthy, identifying, immune, initially, Institute, intensive, isolation, knowledge, leader, likelihood, linked, mark, nonowner, osteoporotic, par, participant, peptic, platform, play, positional, preceding, progression, rapid, regulating, repayable, role, selection, sequenced, side, skin, sophisticated, stomach, strong, succeed, surface, targeted, telephone, transition, ulcer, University, utilization, validate, variable, voting, washington, wound
Filing tables
Filing exhibits
- 10-K Annual report
- 10.39 Employment Letter with Dominick Colangelo
- 10.40 Employment Letter with Antonius Bunt
- 12.1 Statement Re: Computation of Ratios
- 23.1 Consent of Ernst & Young LLP
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32.1 Certification of Chief Executive Officer Pursuant to Section 906
- 32.2 Certification of Chief Financial Officer Pursuant to Section 906
OSCI similar filings
Filing view
External links
Exhibit 12.1
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
For the Year Ended December 31, | Proforma | |||||||||||||||||||||||
2000 | 2001 | 2002 | 2003 | 2004 | 2004 | |||||||||||||||||||
Earnings (loss) – | ||||||||||||||||||||||||
Loss before income taxes | $ | (5,847 | ) | $ | (10,090 | ) | $ | (34,017 | ) | $ | (29,789 | ) | $ | (93,271 | ) | $ | (95,732 | ) | ||||||
Add fixed Charges: | ||||||||||||||||||||||||
Interest expense on indebtedness | $ | 843 | $ | 692 | $ | 1,936 | $ | 990 | $ | 4,480 | $ | 6,537 | ||||||||||||
Estimated interest on rental expense | 305 | 341 | 329 | 300 | 1,721 | 1,721 | ||||||||||||||||||
Amortization of deferred closing costs related to convertible notes | — | — | 294 | 156 | 521 | 893 | ||||||||||||||||||
Amortization of discount on convertible notes | — | — | 511 | 271 | ||||||||||||||||||||
Total Adjusted Loss | $ | (4,699 | ) | $ | (9,057 | ) | $ | (30,947 | ) | $ | (28,072 | ) | $ | (86,549 | ) | $ | (86,581 | ) | ||||||
Fixed Charges – | ||||||||||||||||||||||||
Interest expense on indebtedness | $ | 843 | $ | 692 | $ | 1,936 | $ | 990 | $ | 4,480 | $ | 6,537 | ||||||||||||
Estimated interest on rental expense | 305 | 341 | 329 | 300 | 1,721 | 1,721 | ||||||||||||||||||
Amortization of deferred closing costs related to convertible notes | — | — | 294 | 156 | 521 | 893 | ||||||||||||||||||
Amortization of discount on convertible notes | — | — | 511 | 271 | ||||||||||||||||||||
Total Fixed Charges | $ | 1,148 | $ | 1,033 | $ | 3,070 | $ | 1,717 | $ | 6,722 | $ | 9,151 | ||||||||||||
Coverage deficiency | $ | (5,847 | ) | $ | (10,090 | ) | $ | (34,017 | ) | $ | (29,789 | ) | $ | (93,271 | ) | $ | (95,732 | ) | ||||||